Radiation therapy for recurrent rapid heartbeat
Part of Heart & circulation clinical trials.
This trial tests whether a precise, one-time radiation treatment (usually used for cancer) can reduce episodes of a dangerous rapid heartbeat called ventricular tachycardia. It may offer an option for people who have not been helped by other treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You have had ventricular tachycardia (a fast, abnormal heartbeat) that caused symptoms or required a shock from an implanted defibrillator in the past 6 months.
- Your doctor can identify a specific spot in your heart that is causing the abnormal rhythm.
- You must not have a reversible cause for the rapid heartbeat, such as a recent heart attack or drug side effects.
- You must be able to lie still for the radiation treatment and fit on the treatment table.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new way to plan and deliver precise radiation (radioablation) to the heart to treat a dangerous rapid heartbeat called monomorphic ventricular tachycardia. It aims to improve imaging and treatment planning so that radiation can be targeted more safely and effectively.
This trial studies a non-invasive treatment using focused radiation to target the heart tissue causing dangerous heart rhythms. It may be an option for people who have already had a catheter ablation but still get episodes of ventricular tachycardia.
This trial compares two treatments—radiation therapy or catheter ablation—for people with structural heart disease who have a type of fast heart rhythm called ventricular tachycardia. It aims to see which approach works better to prevent repeat episodes.
This trial studies using a precise type of radiation (stereotactic ablative radiotherapy) to treat abnormal heart rhythms when medicines or prior procedures haven’t worked. It may help by targeting the heart area causing the rhythm problem without doing another invasive ablation.
This trial studies a radiation approach (called stereotactic body radiation therapy, or SBRT) to treat ventricular tachycardia (a dangerous heart rhythm) that keeps coming back. It aims to reduce the rhythm episodes in people who have already tried catheter ablation (a procedure to cauterize rhythm sources) or cannot have it.
This Phase 2 study tests a precise form of radiation therapy to control recurrent ventricular tachycardia (VT), a dangerous fast heart rhythm. It may help people whose VT keeps coming back despite heart medicines and/or ablation, especially when ablation is not possible.
Hear when a new Ventricular Tachycardia, Monomorphic trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.